On January 6, 2026, the FDA issued a Guidance for Industry and Food and Drug Administration Staff regarding Clinical Decision Support (CDS) ...
The fetus is an allograft onto the mother and is at risk of rejection, so there is a strong T helper 2 (T H 2)-cell bias to fetal innate immune responses, a tendency also initially manifest in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results